Skip to content

Depression and anxiety in women with and without polycystic ovary syndrome: a case-control study

Depression and anxiety in women with and without polycystic ovary syndrome: a case-control study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035335
Enrollment
Unknown
Registered
2020-08-08
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

PCOS group:Nil
control group:Nil

Sponsors

Union Hospital affiliated to Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. PCOS group: Meet the diagnostic criteria of Rotterdam in 2003: (1) Patients with rare ovulation or even no ovulation; (2) The clinical symptoms or biochemical manifestations of the patient showed hyperandrogenemia; (3) Color ultrasound of the abdomen showed polycystic ovary changes (vaginal color ultrasound showed that one or both ovaries contained more than 12 follicles of 2-9mm); If two of the three criteria are met, a diagnosis can be made. 2. Control group: (1) Normal menstrual cycle (28-35 days); (2) No clinical symptoms of excessive androgens; (3) Normal serum androgen level; (4) No polycystic changes were observed in abdominal color doppler ultrasound; (5) There is no history without education. 3. Age: 18~50 years old women of childbearing age. 4. Did not receive any oral contraceptives, other forms of hormonal contraception or fertility treatment for at least 3 months, and did not receive progesterone treatment for at least 1 month prior to study participation. 5. Never received any cholesterol-lowering drug, antihypertensive drug, insulin sensitizer, metformin or any other diabetes 6. Did not take any sedatives or antidepressants for at least 3 months.

Exclusion criteria

Exclusion criteria: (1) Pregnant and lactating women. (2) Patients with thyroid diseases and hyperprolactinemia. (3) Patients who have undergone ovarian or uterine surgery. (4) Patients with congenital adrenal hyperplasia, Cushing's syndrome, androgen secreting tumors.

Design outcomes

Primary

MeasureTime frame
Hospital Anxiety and Depression Scale;

Secondary

MeasureTime frame
Sex hormone levels;blood lipid level;fasting blood-glucose;fasting insulin;

Countries

China

Contacts

Public ContactLiu Yi
liqun94@163.com+86 13971038710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026